The benefits of cannabis are now incontrovertible.
There’s something for everyone--especially those who seek some kind of euphoria or relief from emotional stress. Strains are crafted and curated for maximal palliative psychoactive properties--from terpenoids to flavonoids, from edibles to vapes. Sativa for staving off doldrums; Indica for staving off anxiety.THC is ideal for pain mitigation. Analgesics like CBC are ideal for reducing inflammation. Anti-convulsants like CBDV are great for preventing muscle spasms. Anti-microbials like CBN are great for relaxation. At the end of the day, this is all about health and wellness.
Most dispensaries offer a wide variety of premium cannabis--from the energizing effects of Sativa to the sedative effects of Indica. Different cannabis strains contain different constituent profiles, medicinal qualities, and potency. THC is for more euphoric effects, whereas CBD is for alleviating anxiety. There is also a vast assortment of terpenes--most notably pinene, linalool, limonene, myrcene, humulene, eucalyptol, and caryophyllene. One can also opt for one’s choice of flavonoids.
Each strain is curated for precisely the effects each person is looking for--be it CBN for calming or CBC for anti-inflammation. Discerning users are looking for the highest quality product, and demand the precise compound for their needs.
Modes of delivery range from smoking and vaping to edibles and capsules. There are topical oils and sublingual droppers. When selecting one’s optimal form of cannabinoid, the idea is to find which flower strain is right for each person. Whether Sativa for mental stimulation or Indica for serenity, the goal is to help people feel amazing.
The cannabis industry is growing rapidly, with annual market values expected to reach $30 billion by 2025. Various new CBD-based products—from edibles to oils—are in various stages of development. New enterprises are springing up across North America—from Harvest Health and Recreation to Vurdo. The online cannabis distributor, Nabis is working to integrate the network of growers, manufacturers, and vendors in order to improve distribution to make products more accessible and affordable.
Yet dispensaries are still forced to navigate a regulatory minefield. The U.S. remains a complicated space for cannabis companies. While cannabis remains illegal at the federal level, more and more states are opening their doors to retailers; and processes that will continue as legalization occurs at the local level. The demand for everything from Sativa to Indica will only grow, and those who offer the best-quality strains will come out on top.